Laddar...
Functional characterization of a novel somatic oncogenic mutation of PIK3CB
Class I phosphoinositide 3-kinase (PI3K) enzymes have attracted considerable attention as drug targets in cancer therapy over the last 20 years. The signaling pathway triggered by class I PI3Ks is dysregulated in a range of tumor types, impacting cell proliferation, survival and apoptosis. Frequent...
Sparad:
| I publikationen: | Signal Transduct Target Ther |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5740215/ https://ncbi.nlm.nih.gov/pubmed/29279775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sigtrans.2017.63 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|